Amgen Inc. (AMGN) Q3 2014 Earnings Results

Amgen Beats on EPS, Stock Up 0.64%

Amgen's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock's slight increase of 0.64% reflects investor confidence, driven by strong performance in key areas. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.30	N/A	+11.92%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their product pipeline and market position. However, they did not provide specific guidance for future quarters.

Management highlighted strong performance in key therapeutic areas.

They noted ongoing investments in R&D to drive future growth.

Amgen Beats on EPS, Stock Up 0.64%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Up 0.64%

Key numbers

Management commentary